Journal of Diabetes Research · 2019 · 23 citations · 46 references
AgricultureNutritionNutritional SciencesGestational DiabetesHuman NutritionMaternal NutritionDiabetes MellitusGlycemic ControlInsulin ResistanceMetabolic SyndromeNutritional ManagementOmega-3 Fatty Acids In PregnancyBiochemical Marker AssessmentBlood Glucose RegulationC-reactive Protein TestingHemoglobin A1c TestingInsulin Resistance AssessmentMetabolic BiomarkersPlacebo-controlled Efficacy AssessmentPregnancy Glucose Profiles
Objective . To investigate the effects of cod-liver oil on metabolic status and high-sensitivity C-reactive protein (hs-CRP) in patients with gestational diabetes mellitus (GDM). Methods . This study was a randomized, double-blinded, placebo-controlled trial with the allocation ratio of 1 : 1. The contents of EPA and DHA in cod-liver oil were measured using a gas chromatograph. A total of 550 GDM patients were randomly divided into the intervention group (cod-liver oil) and the control group (placebo, mineral oil), and both groups were given regular dietary care. Glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG), lipid profiles, homeostatic model assessment insulin resistance (HOMA-IR), and hs-CRP were measured. Primary outcomes were different in HbA1c, FPG, 2hPG, and HOMA-IR between the two groups after 4-week randomization. Secondary outcomes were the blood glucose levels and perinatal complications (pregnancy-induced hypertension, polyhydramnios, premature delivery, postpartum hemorrhage, postpartum infection, premature rupture of membranes, and cesarean section) between the two groups before and after 12-16 weeks of cod-liver oil intervention from middle pregnancy to late pregnancy. Results . EPA and DHA were the main components of cod-liver oil with 76 mg/mL and 150 mg/mL, respectively. There was no significant difference for primary outcomes in the levels of HbA1c, FPG, 2hPG, HOMA-IR, and lipid profiles between the two groups (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>P</mml:mi><mml:mo>></mml:mo><mml:mn>0.05</mml:mn></mml:math>). For the secondary outcomes, the levels of HbA1c, FPG, 2hPG, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol ratio (LDL-C), HOMA-IR, and hs-CRP in the intervention group were significantly lower than those in the control group (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.05</mml:mn></mml:math>). The incidence of perinatal complications in the intervention group was lower than that in the control group too (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>0.05</mml:mn></mml:math>). Conclusions . Cod-liver oil consumption effectively reduced the levels of blood glucose, lipid levels, hs-CRP, and HOMA-IR and the incidence of perinatal complications.
46
Dietary fat intakes for pregnant and lactating women
British Journal Of Nutrition · 2007 · 386 citations · Full text
MS Christensen, C. ‐E. Høy, CC Becker et al. · American Journal of Clinical Nutrition · 1995 · 240 citations · Full text
Etiology and pathogenesis of gestational diabetes.
Christiane Kühl · PubMed · 1998 · 202 citations
Medicine, Endocrinology, Obstetrics +16